Pseudosystemic sclerosis as a complication of recombinant human interleukin 2 (aldesleukin) therapy. The British journal of dermatology [Br J Dermatol] Journal article

Title	Pseudosystemic sclerosis as a complication of recombinant human interleukin 2 (aldesleukin) therapy.
Author(s)	Marie I, Joly P, Courville P, Levesqsue H
Institution	Departments of Internal Medicine, Rouen University Hospital, 76031 Rouen Cedex, France.
Source	Br J Dermatol 2007 Jan; 156(1):182-3.
Language	eng
Pub Type(s)	Journal Article
PubMed ID	17199595

Advertise on this site.